MedTrace Logo

SCAD : a Registry of Spontaneous Coronary Artery Dissection

NCT06601270 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-10-29

No results posted yet for this study

Summary

Spontaneous coronary artery dissection (SCAD) is an increasingly recognised cause of non-atherosclerotic acute coronary syndromes (ACS), predominantly afflicting young women without conventional atherosclerotic risk factors. Knowledge of SCAD has advanced considerably in the last few years as a result of data from a number of local and national registries 1-6. Like all rarer diseases however, a better understanding of SCAD will require international collaboration. At present, there is no European or International SCAD registry despite increasing recognition that there are key differences in the diagnosis, interventional and medical management of SCAD compared with conventional atherosclerotic ACS. The ESC-ACCA Study Group on Spontaneous Coronary Artery Dissection supported by the European Observational Research Programme will now build the first pan-European SCAD registry to advance our understanding of current management of this condition, inform guidelines, educate clinical colleagues and advance research.

Conditions

  • Spontaneous Coronary Artery Dissection

Interventions

OTHER

There are no interventions as the study is purely observational.

There are no interventions as the study is purely observational.

Sponsors & Collaborators

Principal Investigators

  • Adham GHARIEB, PharmD · ESC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-30
Primary Completion
2026-10-31
Completion
2027-10-31

Countries

  • Argentina
  • Austria
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • France
  • Germany
  • Greece
  • Iran
  • Italy
  • Netherlands
  • New Zealand
  • Norway
  • Poland
  • Portugal
  • Serbia
  • Singapore
  • Slovakia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06601270 on ClinicalTrials.gov